(19)
(11) EP 3 258 869 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
29.04.2020 Bulletin 2020/18

(45) Mention of the grant of the patent:
25.03.2020 Bulletin 2020/13

(21) Application number: 16708281.7

(22) Date of filing: 12.02.2016
(51) International Patent Classification (IPC): 
A61B 18/02(2006.01)
(86) International application number:
PCT/US2016/017828
(87) International publication number:
WO 2016/133826 (25.08.2016 Gazette 2016/34)

(54)

CRYONEEDLE

KRYONADEL

AIGUILLE CRYOGÉNIQUE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 20.02.2015 US 201514627568

(43) Date of publication of application:
27.12.2017 Bulletin 2017/52

(60) Divisional application:
20165024.9

(73) Proprietor: Boston Scientific Scimed, Inc.
Maple Grove, MN 55311 (US)

(72) Inventors:
  • RAMADHYANI, Satish
    Minneapolis, Minnesota 55414 (US)
  • ZACHMAN, Andrew Kevin
    St. Michael, Minnesota 55376 (US)
  • BLEIWIES, Modechay
    Kiryat Motzkin 2623197 (IL)
  • JOHNSON, Mark Timothy
    Mounds View, Minnesota 55112 (US)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
P.O. Box 86 07 67
81634 München
81634 München (DE)


(56) References cited: : 
WO-A2-2005/000106
GB-A- 2 336 781
US-A1- 2007 149 959
US-A1- 2011 022 040
US-B1- 6 270 476
 WO-A2-2014/144626
US-A1- 2006 122 590
US-A1- 2010 256 620
US-A1- 2012 065 630
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).